NCT05685849

Evaluation of Maternal Fetal Cardiac Structure and Function in Pregnancies With Cardiovascular Disease

Name: Clinical Trial NCT05685849
Creator: First Hospital of China Medical University
Keywords: Pregnancy, Echocardiography, device, clinical trial, China

Valuation of Maternal Fetal Cardiac Structure and Function in Pregnancies With Cardiovascular Disease：a Prospective, Multicenter, Clinical Trial

First Hospital of China Medical University·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Pregnancy
Drug/Device/Intervention: Echocardiography
Study type: Observational
Intervention type: device

Sponsor & location

Primary sponsor: First Hospital of China Medical University
Location: Jiamusi,Zhengzhou,Dalian,Jinzhou,Shenyang,Shenyang,Shenyang,Xi'an,Weifang,Kunming, China

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2023
End date: Jan 31, 2025
Enrollment: 200 participants

Primary outcome

Left ventricular ejection fraction

Summary

The First Affiliated Hospital of China Medical University initiated a multi-center study to evaluate the changes of maternal fetal heart structure and function in pregnancies with cardiovascular disease by echocardiography, to explore the impact of cardiovascular disease on maternal fetal heart, so as to provide an important reference for obstetric pregnancy risk stratification and management.

ICD-10 classifications

Pregnancy confirmedPregnancy-related condition, unspecifiedAbdominal pregnancyPregnancy, not (yet) confirmedOvarian pregnancy

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05685849
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05685849 through Pure Global AI's free database. This phase not specified trial is sponsored by First Hospital of China Medical University and is currently Recruiting. The study focuses on Pregnancy. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.